Staar Surgical Co (STAA)
35.07
+0.91
(+2.66%)
USD |
NASDAQ |
Oct 04, 16:00
35.06
-0.01
(-0.03%)
After-Hours: 20:00
Staar Surgical Research and Development Expense (Annual): 44.40M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.40M |
| December 31, 2022 | 35.98M |
| December 31, 2021 | 33.86M |
| December 31, 2020 | 31.92M |
| December 31, 2019 | 25.30M |
| December 31, 2018 | 22.03M |
| December 31, 2017 | 20.04M |
| December 31, 2016 | 20.67M |
| December 31, 2015 | 14.76M |
| December 31, 2014 | 14.76M |
| December 31, 2013 | 6.708M |
| December 31, 2012 | 6.444M |
| December 31, 2011 | 5.868M |
| December 31, 2010 | 5.724M |
| December 31, 2009 | 5.893M |
| Date | Value |
|---|---|
| December 31, 2008 | 7.938M |
| December 31, 2007 | 6.711M |
| December 31, 2006 | 7.08M |
| December 31, 2005 | 5.573M |
| December 31, 2004 | 6.246M |
| December 31, 2003 | 5.12M |
| December 31, 2002 | 4.016M |
| December 31, 2001 | 3.80M |
| December 31, 2000 | 4.215M |
| December 31, 1999 | 4.30M |
| December 31, 1998 | 3.60M |
| December 31, 1997 | 3.90M |
| December 31, 1996 | |
| December 31, 1995 | 3.30M |
| December 31, 1994 | 2.70M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
25.30M
Minimum
2019
44.40M
Maximum
2023
34.29M
Average
33.86M
Median
2021
Research and Development Expense (Annual) Benchmarks
| The Cooper Companies Inc | 137.40M |
| OrthoPediatrics Corp | 10.20M |
| NexGel Inc | 0.103M |
| Innovative Eyewear Inc | 0.6622M |
| Abbott Laboratories | 2.741B |